Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KMT5AP2 is a pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional KMT5A gene, which encodes a lysine methyltransferase active in chromatin regulation. There is no evidence that KMT5AP2 encodes a functional protein or that it plays a role in biological processes, disease, or serves as a therapeutic target[7]. KMT5A, by contrast, is an active enzyme with clear roles in histone methylation and disease, but KMT5AP2 is simply a related pseudogene without known molecular or therapeutic functionality[7]. If information on the active KMT5A enzyme is needed, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KMT5A pseudogene 2 (KMT5AP2).